Providence Cancer Institute, Franz Clinic - Eastside ( Site 0107) — Portland, Oregon

Providence Cancer Institute, Franz Clinic - Eastside ( Site 0107) is a clinical research site located in Portland, Oregon, United States 97213.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Providence Cancer Institute, Franz Clinic - Eastside ( Site 0107) has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Small Cell Lung Cancer Extensive Stage, Carcinoma, Non-Small-Cell Lung.

Sponsors: Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Portland

Browse all research sites in Oregon · View every site in Portland

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Providence Cancer Institute, Franz Clinic - Eastside ( Site 0107)?

Providence Cancer Institute, Franz Clinic - Eastside ( Site 0107) has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Providence Cancer Institute, Franz Clinic - Eastside ( Site 0107) conducted?

Providence Cancer Institute, Franz Clinic - Eastside ( Site 0107) has 2 clinical trials on record, with 1 currently active. Their work covers Small Cell Lung Cancer Extensive Stage, Carcinoma, Non-Small-Cell Lung.

Is Providence Cancer Institute, Franz Clinic - Eastside ( Site 0107) accredited by Crixeo Clinical Trials?

Providence Cancer Institute, Franz Clinic - Eastside ( Site 0107) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Providence Cancer Institute, Franz Clinic - Eastside ( Site 0107)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.